Design, synthesis and evaluation of monoketene compounds as novel potential Parkinson's disease agents by suppressing ER stress via AKT.
Alzforum,
Chen J, Zheng Z, Li M, Cao C, Zhou X, Wang B, Gan X, Huang Z, Liu Y, Huang W, Liang F, Chen K, Zhao Y, Wang X, Wu J, Lin L.